Trial intelligence / Profile preview

Ozone vs Lidocaine Injections for Piriformis Syndrome

NCT06130618Unknown

Sponsor
Ankara City Hospital
Start
Sep 2023
Primary completion
Mar 2024
Modality
Inhalation Devices
Countries
1
01

Overview

Randomised trial of medical ozonated water in Piriformis syndrome (2 arms), sponsored by Ankara City Hospital. Primary endpoints: Pain condition evaluated by Visual Analog Scale at 3 months, Posture evaluation at 3 months and 1 more. Status: unknown.

02

Drugs

medical ozonated water
03

Conditions

Piriformis syndrome

Beyond the preview

Go deeper on NCT06130618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06130618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call